News

June 26 (Reuters) - Home health and hospice caregiver Amedisys (AMED.O), opens new tab on Monday agreed to a $3.3 billion sweetened cash offer from UnitedHealth Group (UNH.N), opens new tab and ...
Amedisys (NASDAQ:AMED) earlier ticked down 0.2% on a report that the Dept. of Justice has initially rejected the proposed divestiture buyers for its planned sale to UnitedHealth (NYSE:UNH). The DOJ ...
Amedisys, Inc. BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three ...
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Here is how Amedisys (AMED) and BrightSpring Health Services ...
A month has gone by since the last earnings report for Amedisys (AMED). Shares have lost about 0.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...
Yet another shoe has dropped in the UnitedHealth Group/Amedisys saga. Last week, the Justice Department — along with the Attorneys General of Maryland, Illinois, New Jersey, and New York ...
Amedisys, a large home health provider, plans to divest a number of care centers to an affiliate of VitalCaring Group in advance of its planned merger with UnitedHealth Group later this year.
Amedisys said its $3.29 billion merger with UnitedHealth Group will close in the second half of 2024, and it plans to divest some home health care centers after the deal closes. The number and ...
Amedisys on Monday agreed to be acquired by UnitedHealth's Optum unit in an all-cash deal while also scraping a previous all-stock deal offer from Option Care Health. Optum is buying the company ...
Healthcare behemoth UnitedHealth and home health and hospice provider Amedisys have zeroed in on the assets they plan to divest to get federal regulators on board with their $3.3 billion merger.
Home health provider Amedisys said Thursday it will begin offering in-home molecular testing to patients that will help quickly identify urine, respiratory and wound infection pathogens.